Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the sector of biopharmaceuticals, presenting promising breakthroughs across numerous medical and industrial programs. With its structural similarity to Normally derived human serum albumin, OsrHSA presents a safer, much more dependable choice for therapeutic use, esp